Active substance · J07AG51
Haemophilus influenzae type b-prp and tetanus toxoid conjugate
Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07A
- Chemical subgroupJ07AGHemophilus influenzae b vaccines
- Chemical substanceJ07AG51Hemophilus influenzae b, combinations with toxoids
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 2 medicines
All medicines with Haemophilus influenzae type b-prp and tetanus toxoid conjugate
Every register, a page at a time. Strengths and packs are on each medicine’s page.
2 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Infanrix-Ipv/HibCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Hiberix | Canada | 10 MCG / 0.5 ML | Powder For Solution | Cancelled | Glaxosmithkline INC |